These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution? Candiotti KA; Gitlin MC Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361 [TBL] [Abstract][Full Text] [Related]
3. [Development of opioid tolerance -- molecular mechanisms and clinical consequences]. Freye E; Latasch L Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725 [TBL] [Abstract][Full Text] [Related]
4. Addressing opioid tolerance and opioid-induced hypersensitivity: Recent developments and future therapeutic strategies. Khan F; Mehan A Pharmacol Res Perspect; 2021 May; 9(3):e00789. PubMed ID: 34096178 [TBL] [Abstract][Full Text] [Related]
5. The bidirectional relationship between opioids and the gut microbiome: Implications for opioid tolerance and clinical interventions. Taboun ZS; Sadeghi J Int Immunopharmacol; 2023 Dec; 125(Pt A):111142. PubMed ID: 37918085 [TBL] [Abstract][Full Text] [Related]
6. Something for pain: Responsible opioid use in emergency medicine. Strayer RJ; Motov SM; Nelson LS Am J Emerg Med; 2017 Feb; 35(2):337-341. PubMed ID: 27802876 [TBL] [Abstract][Full Text] [Related]
7. New concepts in opioid analgesia. Stein C Expert Opin Investig Drugs; 2018 Oct; 27(10):765-775. PubMed ID: 30148648 [TBL] [Abstract][Full Text] [Related]
8. Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain. Beaudry H; Gendron L; MorĂ³n JA Eur J Neurosci; 2015 Apr; 41(7):901--7. PubMed ID: 25639561 [TBL] [Abstract][Full Text] [Related]
9. The role of the gut microbiome in opioid use. Ren M; Lotfipour S Behav Pharmacol; 2020 Apr; 31(2&3):113-121. PubMed ID: 31895059 [TBL] [Abstract][Full Text] [Related]
10. Opioids for the treatment of arthritis pain. Stein C; Baerwald C Expert Opin Pharmacother; 2014 Feb; 15(2):193-202. PubMed ID: 24283649 [TBL] [Abstract][Full Text] [Related]
14. Responsible prescribing of opioids for the management of chronic pain. Nicholson B Drugs; 2003; 63(1):17-32. PubMed ID: 12487620 [TBL] [Abstract][Full Text] [Related]
15. Opioids for chronic nonterminal pain. Ballantyne JC South Med J; 2006 Nov; 99(11):1245-55. PubMed ID: 17195420 [TBL] [Abstract][Full Text] [Related]
16. Opioids for persistent noncancer pain. McCleane G; Smith HS Med Clin North Am; 2007 Mar; 91(2):177-97. PubMed ID: 17321280 [TBL] [Abstract][Full Text] [Related]
17. Opioid tolerance and dependence -- do they matter? Jage J Eur J Pain; 2005 Apr; 9(2):157-62. PubMed ID: 15737807 [TBL] [Abstract][Full Text] [Related]
18. [Pain inhibition by opioids-new concepts]. Stein C Anaesthesist; 2019 Feb; 68(2):97-103. PubMed ID: 30645691 [TBL] [Abstract][Full Text] [Related]
19. Opioid Receptors. Stein C Annu Rev Med; 2016; 67():433-51. PubMed ID: 26332001 [TBL] [Abstract][Full Text] [Related]
20. Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine. Zadina JE; Nilges MR; Morgenweck J; Zhang X; Hackler L; Fasold MB Neuropharmacology; 2016 Jun; 105():215-227. PubMed ID: 26748051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]